DTTC with Caregiver Training for Childhood Apraxia of Speech
(DTTC Trial)
Trial Summary
What is the purpose of this trial?
This trial tests which type of caregiver training helps children with childhood apraxia of speech improve their speaking abilities more effectively. Children receive specialized speech therapy and practice at home with their caregivers. The study aims to see which method leads to better speech accuracy and communication skills.
Will I have to stop taking my current medications?
The trial does not specify whether participants need to stop taking their current medications. However, children with ADHD can participate if they can attend sessions with medication and/or strategies.
What data supports the effectiveness of the treatment Dynamic Temporal and Tactile Cueing (DTTC) for Childhood Apraxia of Speech?
Is Dynamic Temporal and Tactile Cueing (DTTC) safe for humans?
How is the DTTC treatment different from other treatments for childhood apraxia of speech?
DTTC (Dynamic Temporal and Tactile Cueing) is unique because it focuses on motor-based intervention, using specific timing and touch cues to help children with childhood apraxia of speech improve their speech intelligibility. This approach is different from other treatments that may not emphasize the same level of motor planning and tactile feedback.12458
Research Team
Eligibility Criteria
This trial is for children aged between 2 years and 5 months to 7 years and 11 months with a primary diagnosis of Childhood Apraxia of Speech (CAS) who speak English as their main language. Kids with autism, global developmental delay, Down syndrome, or severe hearing or visual impairments can't join. Those already receiving speech treatment elsewhere are also excluded.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-Treatment
Caregivers complete an online self-guided educational module about CAS and DTTC
Treatment
Participants receive DTTC treatment 2x/week for 8 weeks with home practice 3x/week
Follow-up
Home practice continues at a higher frequency (6x/week) to monitor treatment outcomes
Treatment Details
Interventions
- Dynamic Temporal and Tactile Cueing (DTTC) (Behavioral Intervention)
Dynamic Temporal and Tactile Cueing (DTTC) is already approved in Canada for the following indications:
- Childhood Apraxia of Speech (CAS)
Find a Clinic Near You
Who Is Running the Clinical Trial?
New York University
Lead Sponsor
Dr. Fritz François
New York University
Chief Medical Officer
MD from NYU Grossman School of Medicine
Dr. Robert I. Grossman
New York University
Chief Executive Officer since 2007
MD from NYU Grossman School of Medicine
Hofstra University
Collaborator